Immunovant Inc (IMVT)

Finanzdaten der Immunovant Inc-Aktie (IMVT)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	6.20% 8.379	8.933	3.572	4.065	3.48
Operating Expenses	31.40% 80.88	61.55	61.80	78.48	64.26
Benefits Costs and Expenses	38.05% 83.47	60.46	61.78	78.01	63.90
Costs And Expenses	38.05% 83.47	60.46	61.78	78.01	63.90
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	37.78% -72.50	-52.62	-58.23	-74.41	-60.78
Net Interest Income/Expense	6.20% 8.379	8.933	3.572	4.065	3.48
Interest Income/Expense After Provision For Losses	6.20% 8.379	8.933	3.572	4.065	3.48
Income/Loss From Continuing Operations Before Tax	45.73% -75.09	-51.53	-58.21	-73.95	-60.42
Income Tax Expense/Benefit	314.81% 0.232	-0.108	0.454	-0.011	-0.991
Income/Loss From Continuing Operations After Tax	46.48% -75.32	-51.42	-58.66	-73.94	-59.43
Net Income/Loss	46.48% -75.32	-51.42	-58.66	-73.94	-59.43
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	98.25% 2.5233	144.52	131.16	130.50	2.41
Diluted Average Shares	98.25% 2.5233	144.52	131.16	130.50	2.41
Basic Earnings Per Share	44.44% -0.52	-0.36	-0.45	-0.57	-0.45
Diluted Earnings Per Share	44.44% -0.52	-0.36	-0.45	-0.57	-0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-